 CARLSBAD, Calif., Jan. 10, 2023 GLOBE NEWSWIRE Qualigen Therapeutics, Inc. Qualigen or the Company, Nasdaq: QLGN, a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that the U.S. Food and Drug Administration FDA has granted Orphan Drug... The post Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administr... 